Exclusive | Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source

Hong Kong continues strengthening its position as a global biotech and innovation hub through its latest investment drive. A sixth cohort of 22 prominent multinational corporations, including pharmaceutical giants Pfizer and Amgen, has committed to expanding operations in the territory. The initiative also encompasses biotech firms like Boehringer Ingelheim and Hengrui, alongside emerging players in mobility solutions such as DiDi and AutoFlight, signaling diversified growth across multiple strategic sectors.